Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Prepaid Assets of $6000.0 for Q4 2025, up 200.0% sequentially from $2000.0 in Q3 2025, and little changed YoY from $6000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Prepaid Assets for 6 years, with the latest figure at $6000.0 in Q4 2025.
- Quarterly Prepaid Assets changed 0.0% year-over-year to $6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $6000.0, changed 0.0% from the prior year.
- Prepaid Assets grew to $6000.0 in Q4 2025 per RAPH's latest filing, from $2000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $177000.0 in Q4 2021 and troughed at $2000.0 in Q3 2025.
- A 5-year average of $44444.4 and a median of $25500.0 in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets jumped 296.15% in 2023, then slumped 91.26% in 2024.
- Over 5 years, Prepaid Assets stood at $177000.0 in 2021, then sank by 75.71% to $43000.0 in 2022, then plunged by 83.72% to $7000.0 in 2023, then decreased by 14.29% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6000.0, $2000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 177,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Dec 31, 2020 | 228,000.00 |